JP2023134518A5 - - Google Patents

Info

Publication number
JP2023134518A5
JP2023134518A5 JP2023104610A JP2023104610A JP2023134518A5 JP 2023134518 A5 JP2023134518 A5 JP 2023134518A5 JP 2023104610 A JP2023104610 A JP 2023104610A JP 2023104610 A JP2023104610 A JP 2023104610A JP 2023134518 A5 JP2023134518 A5 JP 2023134518A5
Authority
JP
Japan
Prior art keywords
methods
substantially described
novel products
manufacturing methods
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023104610A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023134518A (ja
Filing date
Publication date
Priority claimed from PCT/US2017/031170 external-priority patent/WO2017192923A1/en
Application filed filed Critical
Publication of JP2023134518A publication Critical patent/JP2023134518A/ja
Publication of JP2023134518A5 publication Critical patent/JP2023134518A5/ja
Pending legal-status Critical Current

Links

JP2023104610A 2016-05-05 2023-06-27 透過性増強された医薬組成物 Pending JP2023134518A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662331993P 2016-05-05 2016-05-05
US62/331,993 2016-05-05
PCT/US2017/031170 WO2017192923A1 (en) 2016-05-05 2017-05-04 Pharmaceutical compositions with enhanced permeation
JP2018558225A JP2019519488A (ja) 2016-05-05 2017-05-04 透過性増強された医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018558225A Division JP2019519488A (ja) 2016-05-05 2017-05-04 透過性増強された医薬組成物

Publications (2)

Publication Number Publication Date
JP2023134518A JP2023134518A (ja) 2023-09-27
JP2023134518A5 true JP2023134518A5 (enExample) 2026-05-13

Family

ID=58708068

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018558225A Pending JP2019519488A (ja) 2016-05-05 2017-05-04 透過性増強された医薬組成物
JP2023104610A Pending JP2023134518A (ja) 2016-05-05 2023-06-27 透過性増強された医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018558225A Pending JP2019519488A (ja) 2016-05-05 2017-05-04 透過性増強された医薬組成物

Country Status (9)

Country Link
US (1) US20170290776A1 (enExample)
EP (1) EP3452024A1 (enExample)
JP (2) JP2019519488A (enExample)
KR (1) KR102536696B1 (enExample)
CN (1) CN109310647A (enExample)
BR (1) BR112018072467A2 (enExample)
CA (1) CA3022797A1 (enExample)
IL (2) IL318880A (enExample)
WO (1) WO2017192923A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
WO2018091473A1 (en) 2016-11-15 2018-05-24 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2018129499A1 (en) * 2017-01-09 2018-07-12 Verily Life Sciences Llc Systems and methods for wearable emergency drug injection devices
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
KR102845228B1 (ko) * 2017-09-27 2025-08-14 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 투과를 가지는 약물학적 조성물
JP2020535162A (ja) * 2017-09-27 2020-12-03 アクエスティブ セラピューティクス インコーポレイテッド 増強された送達のエピネフリン及びプロドラッグ組成物
CN107903322B (zh) * 2017-10-10 2022-03-08 宜宾学院 一种基于黄樟素环氧化改性制备抗菌胶原的方法
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020006073A1 (en) 2018-06-28 2020-01-02 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
BR112021004053A2 (pt) 2018-09-07 2021-05-25 Aquestive Therapeutics, Inc. composições de filme oral e formas de dosagem tendo perfis de dissolução de ativo precisos
IL292487A (en) * 2019-11-01 2022-06-01 Aquestive Therapeutics Inc Compositions of medicinal meters and methods of treatment
CA3159389A1 (en) * 2019-11-14 2021-05-20 Aquestive Therapeutics, Inc. Multimodal compositions comprising diazepam and methods of treatment
JP2023504756A (ja) 2019-12-09 2023-02-06 ニコベンチャーズ トレーディング リミテッド カンナビノイドを含む口腔用製品
DE102020122557A1 (de) * 2020-08-28 2022-03-03 Lts Lohmann Therapie-Systeme Ag Mucosa-Perforierung
US20230364013A1 (en) * 2020-10-08 2023-11-16 Catalent U.K. Swindon Zydis Limited Stable oral dispersible formulation for epinephrine
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment
JP2025029732A (ja) 2023-08-22 2025-03-07 三菱電機株式会社 ゲート駆動装置
CN120037250B (zh) * 2025-04-07 2026-03-03 江苏知原药业股份有限公司 一种伊维菌素外用药物组合物、制备方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1357891A (en) 1920-07-15 1920-11-02 Henry S Murray Portable instantaneous water-heater
US20040265353A1 (en) * 1995-07-28 2004-12-30 Zars, Inc. Systems and methods for treating panic attacks
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
WO2004037222A2 (en) * 2002-10-25 2004-05-06 Labopharm Inc. Sustained-release tramadol formulations with 24-hour efficacy
US20040096569A1 (en) * 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
US20050266085A1 (en) * 2004-05-28 2005-12-01 Warner Kevin S Gelled emulsion and microemulsion formulations for dermal drug delivery
US20070202163A1 (en) * 2005-09-09 2007-08-30 Mutasem Rawas-Qalaji Fast-disintegrating epinephrine tablets for buccal or sublingual administration
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
KR101226165B1 (ko) * 2009-07-23 2013-01-24 가부시키가이샤 이기스 피부 외용제 조성물
EP2590636A1 (en) * 2010-07-06 2013-05-15 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
WO2013063614A1 (en) * 2011-10-28 2013-05-02 Sung-Yun Kwon Dissolving solid solution perforator patch for migraine treatment
JP7653218B2 (ja) * 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物

Similar Documents

Publication Publication Date Title
JP2026048925A5 (enExample)
JP2022538004A5 (enExample)
JP2023113641A5 (enExample)
JP2024156852A5 (enExample)
JP2024133471A5 (enExample)
JP2026012786A5 (enExample)
JP2024037765A5 (enExample)
JP2023113681A5 (enExample)
JP2023154065A5 (enExample)
JP2023164986A5 (enExample)
JP2025023938A5 (enExample)
JP2023153863A5 (enExample)
JP2025106258A5 (enExample)
JP2023103231A5 (enExample)
JP2025118771A5 (enExample)
JP2024156705A5 (enExample)
JP2023134519A5 (enExample)
JP2025038009A5 (enExample)
JP2023139025A5 (enExample)
JP2024088648A5 (enExample)
JP2024156672A5 (enExample)
JP2018100276A5 (enExample)
JP2025143267A5 (enExample)
JP2024160274A5 (enExample)
JP2022025124A5 (enExample)